XOMA

Biotechnology, Developer Platform, Health Care, Therapeutics
Founded in 1/1/81
Berkeley, California, United States
For Profit

About XOMA

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation today. Building on a pioneering proprietary pipeline, a world-class antibody discovery and development platform, plus multiple revenue streams, XOMA is creating innovative human antibody therapeutics with the potential to transform medicine and reshape people's lives.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: 6428
  • Tech Stack: 16 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 155800000 USD
  • Last Funding: 35000000 USD (Post-IPO Equity)
  • Funding Status: IPO

Technology Stack

XOMA actively uses 16 products in their tech stack.

Market Presence

Industries: Biotechnology, Developer Platform, Health Care, Therapeutics

Headquarters: Berkeley, California, United States

Leadership

  • Thomas Burns - Senior Vice President, Finance and CFO LinkedIn
  • Kirk Johnson - VP Development; Preclinical Development & Clinical Pharmacology; BioPharma Consultant & CSO LinkedIn